Literature DB >> 28096468

O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1.

Huabei Guo1, Bing Zhang2, Alison V Nairn1, Tamas Nagy3, Kelley W Moremen1, Phillip Buckhaults4, Michael Pierce5.   

Abstract

To study the regulation of colorectal adenocarcinoma progression by O-GlcNAc, we have focused on the O-GlcNAc-mediated epigenetic regulation of human colon cancer stem cells (CCSC). Xenograft tumors from colon tumor cells with O-linked N-acetylglucosamine transferase (OGT) knockdown grew significantly slower than those formed from control cells, indicating a reduced proliferation of tumor cells due to inhibition of OGT expression. Significant reduction of the CCSC population was observed in the tumor cells after OGT knockdown, whereas tumor cells treated with the O-GlcNAcase inhibitor showed an increased CCSC population, indicating that O-GlcNAc levels regulated the CCSC compartment. When grown in suspension, tumor cells with OGT knockdown showed a reduced ability to form tumorspheres, indicating a reduced self-renewal of CCSC due to reduced levels of O-GlcNAc. ChIP-sequencing experiments using an anti-O-GlcNAc antibody revealed significant chromatin enrichment of O-GlcNAc-modified proteins at the promoter of the transcription factor MYBL1, which was also characterized by the presence of H3K27me3. RNA-sequencing analysis showed an increased expression of MYBL1 in tumor cells with OGT knockdown. Forced overexpression of MYBL1 led to a reduced population of CCSC and tumor growth in vivo, similar to the effects of OGT silencing. Moreover, two CpG islands near the transcription start site of MYBL1 were identified, and O-GlcNAc levels regulated their methylation status. These results strongly argue that O-GlcNAc epigenetically regulates MYBL1, functioning similarly to H3K27me3. The aberrant CCSC compartment observed after modulating O-GlcNAc levels is therefore likely to result, at least in part, from the epigenetic regulation of MYBL1 expression by O-GlcNAc, thereby significantly affecting tumor progression.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  O-linked N-acetylglucosamine (O-GlcNAc); colon cancer; epigenetics; gene knockout; glycosylation; glycosyltransferase; stem cells

Mesh:

Substances:

Year:  2017        PMID: 28096468      PMCID: PMC5354504          DOI: 10.1074/jbc.M116.763201

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  103 in total

1.  Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code.

Authors:  Kaoru Sakabe; Zihao Wang; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-02       Impact factor: 11.205

Review 2.  MYB function in normal and cancer cells.

Authors:  Robert G Ramsay; Thomas J Gonda
Journal:  Nat Rev Cancer       Date:  2008-07       Impact factor: 60.716

3.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

Review 4.  Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.

Authors:  Zhiyuan Ma; Keith Vosseller
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

5.  GlcNAcylation plays an essential role in breast cancer metastasis.

Authors:  Yuchao Gu; Wenyi Mi; Yuqing Ge; Haiyan Liu; Qiong Fan; Cuifang Han; Jing Yang; Feng Han; Xinzhi Lu; Wengong Yu
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

6.  Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling.

Authors:  Huabei Guo; Tamas Nagy; Michael Pierce
Journal:  J Biol Chem       Date:  2014-10-01       Impact factor: 5.157

7.  Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase.

Authors:  R S Haltiwanger; G D Holt; G W Hart
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

8.  Ten-eleven translocation 1 (Tet1) is regulated by O-linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells.

Authors:  Feng-Tao Shi; Hyeung Kim; Weisi Lu; Quanyuan He; Dan Liu; Margaret A Goodell; Ma Wan; Zhou Songyang
Journal:  J Biol Chem       Date:  2013-05-31       Impact factor: 5.157

9.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

Authors:  Emina H Huang; Mark J Hynes; Tao Zhang; Christophe Ginestier; Gabriela Dontu; Henry Appelman; Jeremy Z Fields; Max S Wicha; Bruce M Boman
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

Review 10.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01
View more
  18 in total

Review 1.  "Nutrient-sensing" and self-renewal: O-GlcNAc in a new role.

Authors:  Nikita S Sharma; Ashok K Saluja; Sulagna Banerjee
Journal:  J Bioenerg Biomembr       Date:  2017-12-05       Impact factor: 2.945

2.  O-GlcNAc transferase missense mutations linked to X-linked intellectual disability deregulate genes involved in cell fate determination and signaling.

Authors:  Nithya Selvan; Stephan George; Fatema J Serajee; Marie Shaw; Lynne Hobson; Vera Kalscheuer; Nripesh Prasad; Shawn E Levy; Juliet Taylor; Salim Aftimos; Charles E Schwartz; Ahm M Huq; Jozef Gecz; Lance Wells
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

3.  O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells.

Authors:  Neha M Akella; Giang Le Minh; Lorela Ciraku; Ayonika Mukherjee; Zachary A Bacigalupa; Dimpi Mukhopadhyay; Valerie L Sodi; Mauricio J Reginato
Journal:  Mol Cancer Res       Date:  2020-01-23       Impact factor: 5.852

4.  IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells.

Authors:  Masahiro Shimizu; Nobuyuki Tanaka
Journal:  Oncogene       Date:  2018-10-10       Impact factor: 9.867

Review 5.  Epigenetic Bases of Aberrant Glycosylation in Cancer.

Authors:  Fabio Dall'Olio; Marco Trinchera
Journal:  Int J Mol Sci       Date:  2017-05-06       Impact factor: 5.923

Review 6.  Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.

Authors:  Neha M Akella; Lorela Ciraku; Mauricio J Reginato
Journal:  BMC Biol       Date:  2019-07-04       Impact factor: 7.431

Review 7.  Drug resistance related to aberrant glycosylation in colorectal cancer.

Authors:  Ninon Very; Tony Lefebvre; Ikram El Yazidi-Belkoura
Journal:  Oncotarget       Date:  2017-11-03

8.  O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5.

Authors:  Nan Wu; Mingzuo Jiang; Yuying Han; Haiming Liu; Yi Chu; Hao Liu; Jiayi Cao; Qiuqiu Hou; Yu Zhao; Bing Xu; Xin Xie
Journal:  J Cell Mol Med       Date:  2018-11-28       Impact factor: 5.310

9.  Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseases.

Authors:  Elena Perenthaler; Anita Nikoncuk; Soheil Yousefi; Woutje M Berdowski; Maysoon Alsagob; Ivan Capo; Herma C van der Linde; Paul van den Berg; Edwin H Jacobs; Darija Putar; Mehrnaz Ghazvini; Eleonora Aronica; Wilfred F J van IJcken; Walter G de Valk; Evita Medici-van den Herik; Marjon van Slegtenhorst; Lauren Brick; Mariya Kozenko; Jennefer N Kohler; Jonathan A Bernstein; Kristin G Monaghan; Amber Begtrup; Rebecca Torene; Amna Al Futaisi; Fathiya Al Murshedi; Renjith Mani; Faisal Al Azri; Erik-Jan Kamsteeg; Majid Mojarrad; Atieh Eslahi; Zaynab Khazaei; Fateme Massinaei Darmiyan; Mohammad Doosti; Ehsan Ghayoor Karimiani; Jana Vandrovcova; Faisal Zafar; Nuzhat Rana; Krishna K Kandaswamy; Jozef Hertecant; Peter Bauer; Mohammed A AlMuhaizea; Mustafa A Salih; Mazhor Aldosary; Rawan Almass; Laila Al-Quait; Wafa Qubbaj; Serdar Coskun; Khaled O Alahmadi; Muddathir H A Hamad; Salem Alwadaee; Khalid Awartani; Anas M Dababo; Futwan Almohanna; Dilek Colak; Mohammadreza Dehghani; Mohammad Yahya Vahidi Mehrjardi; Murat Gunel; A Gulhan Ercan-Sencicek; Gouri Rao Passi; Huma Arshad Cheema; Stephanie Efthymiou; Henry Houlden; Aida M Bertoli-Avella; Alice S Brooks; Kyle Retterer; Reza Maroofian; Namik Kaya; Tjakko J van Ham; Tahsin Stefan Barakat
Journal:  Acta Neuropathol       Date:  2019-12-09       Impact factor: 17.088

Review 10.  Role of O-Linked N-Acetylglucosamine Protein Modification in Cellular (Patho)Physiology.

Authors:  John C Chatham; Jianhua Zhang; Adam R Wende
Journal:  Physiol Rev       Date:  2020-07-30       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.